We are excited to announce Matthew Sheridan, Founder at Spotlight Family Office Group has joined the Board of Compos Mentis Medical.
Compos Mentis Medical is at the forefront of delivering new types of medical treatments for many disorders such as depression, addiction, PTSD and bi-polar disorder. The goal is curing as opposed to the “band aids” currently being prescribed by physicians which only treat symptoms and not the underlying causes.
Compos Mentis Medical is funding and managing new psychiatric practices in multiple states which will incorporate new psychedelic medicines and treatment protocols currently in FDA-approved clinical trials. It is not a pharmaceutical company, but its psychiatric doctors will employ these new medications and protocols as they get FDA approval.
Compos Mentis Medical’s doctors will incorporate ketamine initially, but more importantly, their doctors are at the forefront of incorporating new and better psychedelics as they become available.
This opportunity is exclusive to Spotlight Family Office Group and we welcome you to meet the Compos Mentis Medical management team